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Guidelinepharmacological and psychological management of procedure-related pain and distress.
Methods: Of the international inter-disciplinary CPG development panel (44 individuals), two
working groups including 13 healthcare professionals focused on procedural pain and distress.
Grading of Recommendations Assessment, Development and Evaluation methodology was
used, including the use of systematic literature reviews to inform recommendations and the
use of evidence to decision frameworks. At an in-person meeting in February 2018, the guide-
line panel discussed these frameworks and formulated recommendations which were then dis-
cussed with a patient-parent panel consisting of 4 survivors and 5 parents.
Results: The systematic reviews led to the inclusion of 48 randomised controlled trials (total
number of participants Z 2271). Quality of evidence supporting the recommendations ranged
from very low to moderate. Strong recommendations were made for the use of topical anes-
thetics in all needle procedures, for offering deep sedation (DS)/general anesthesia (GA) to all
children undergoing lumbar puncture, for the use of DS/ GA in major procedures in children
of all ages, for the use of hypnosis in all needle procedures and for the use of active distraction
in all needle procedures.
Conclusion: In this CPG, an evidence-based approach to manage procedure-related pain and
distress in children with cancer is presented. As children with cancer often undergo repeated
needle procedures during treatment, prevention and alleviation of procedure-related pain
and distress is of the utmost importance to increase quality of life in these children and their
families.
ª 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
With the introduction of intensive treatment protocols,
survival rates for childhood cancer in developed countries
have now increased from 40% in the 1970s to over 80%
[1,2]. The drawback of these intensive and prolonged
treatments is that they are often associated with significant
morbidity. Of these side-effects, pain is a key area for
which healthcare professionals seek guidance [3].
In contrast to adult patients with cancer, in whom pain
is mostly tumor related, pain in children with cancer is
mostly related to treatment or procedures [4]. Children
with cancer undergo various potentially painful and/or
distressing needle procedures, such as accessing the cen-
tral venous access port or bone marrow punctures. It is
increasingly acknowledged that children are at risk of
long-term sequelae from inadequate pain management
during needle procedures, for example, increased levels of
anxiety and non-compliance with care [5]. Pain should be
measured and managed, bearing in mind that children
require a developmentally appropriate approach [6].
Guidance is urgently needed for procedural pain in
children with cancer. Major practice variations have been
documented across centers [7]. A recent study showed that
only 10% of institutions had standards for pediatric bone
marrow aspiration pain management [8]. The lack of
attention to pain management practices may negatively
influence health outcomes for children with cancer.
In this clinical practice guideline (CPG), we provide
recommendations regarding pharmacological and psy-
chological interventions for reducing pain and distress
related to needle procedures in children with cancer.This CPG is targeted to healthcare professionals who
care for children with cancer undergoing painful medical
procedures, including pediatric oncologists, nurses, an-
esthesiologists and child life specialists. This CPG is the
first of a series of CPGs focusing on pain in children and
adolescents with cancer.
2. Methods
The full methodology for this guideline development
project has been published separately [9]. A brief sum-
mary is provided here.
2.1. CPG development panel
The CPG development panel comprised 44 international
panel members and was divided into six working
groups. Two working groups focused on pharmacolog-
ical and psychological interventions to reduce pain
related to needle procedures and included three pediatric
oncologists, two pediatric oncology nurses, two clinical
psychologists and a pediatric anesthesiologist, academic
pharmacist, pediatric intensivist, child life specialist,
pediatric oncology researcher and pediatric surgeon. A
core group of eight individuals with experience in CPG
development supervised the process and provided
methodological expertise.
2.2. Scope, definitions and clinical questions
For the purposes of this CPG, needle procedures were
categorised as minor procedures (blood sampling,
E.A.H. Loeffen et al. / European Journal of Cancer 131 (2020) 53e67 55peripheral intravenous access and access to central venous
access port), lumbar puncture procedures (LPs) andmajor
procedures (bone marrow aspiration (BMA), bone
marrow puncture (BMP), combined LP with BMA/BMP,
bone biopsy, organ biopsy and echo-/radiographically
guided punctures). Levels of sedation were defined ac-
cording to the American Society of Anesthesiologists: no
sedation, minimal sedation, moderate sedation, deep
sedation (DS) and general anesthesia (GA) [10].
Refer Table 1 for a full list of clinical questions that
were included. Clinical outcomes for these questions
were prioritised using a simple voting procedure, in
accordance with the Grading of Recommendations
Assessment, Development and Evaluation (GRADE)
methodology [11].2.3. Systematic literature review
For 22 clinical questions, systematic literature searches
were performed (last update March 13th 2018). Rand-
omised controlled trials (RCTs) studying children and
adolescents with cancer were eligible for inclusion.
Study selection, quality appraisal (Cochrane risk of biasTable 1




Patient, intervention, and comparison
1 In children with cancer undergoing a relevant minor proced
of a topical anesthetic vs. any active or passive comparator o
2 In children with cancer undergoing a relevant minor procedu
vs. any active or passive comparator on:
3 In children with cancer
undergoing a relevant
minor procedure, what is the effect of
Sedatives
4 In children with cancer
undergoing a lumbar
puncture procedure, what is the effect of
Level of sedati
5 In children with cancer
undergoing a relevant
major procedure, what is the effect of
Level of sedati
6 In children with cancer undergoing a
relevant procedure, what is the effectof
Hypnosis
7 In children with cancer undergoing a
relevant procedure, what is the effect of
Distraction
8 In children with cancer undergoing a
relevant procedure, what is the effect of
Combination o
modalitiestool and GRADE) and data extraction were performed
independently by two reviewers [12e14].2.4. Formulation of recommendations
When formulating recommendations, the CPG devel-
opment panel prioritised the perspective of the patient
and his/her family as most important when formulating
recommendations. Evidence summaries were dissemi-
nated and used to complete evidence to decision (EtD)
frameworks [15]. These frameworks facilitate formula-
tion of recommendations in a systematic and trans-
parent manner by considering the balance between
benefits and harms of an intervention and also other
factors such as costs, feasibility and acceptability. In
February 2018, the results of the systematic review and
the EtD frameworks were discussed during an in-person
guideline panel meeting in Amsterdam attended by 36
members (80%) including 11 of the 13 members (85%) of
the procedural pain working groups. Decisions were
made through group discussion and consensus; final
recommendations had to be supported unanimously.
For questions where the evidence was deemed insuffi-
cient to formulate a recommendation, an approach toPrioritised clinical outcomes
ure, what is the effect
n:
8 - Pain intensity, self-rated
8 - Distress, self-rated
8 - Adverse effects
7 - Behavioral distress
re, what is the effect of oral analgesics Identical to #1
Any active or passive
comparator
Identical to #1
on Any active (mainly other
level of sedation) or passive
comparator
8 - Pain intensity, self-rated
8 - Distress, self-rated
7 - Behavioral distress
7 - Adverse effects
7 - Success of procedure
on Any active (mainly other
level of sedation) or
passive comparator
8 - Pain intensity, self-rated
8 - Distress, self-rated
7 - Behavioral distress
7 - Adverse effects
Any active or passive
comparator
8 - Pain intensity, self-rated
8 - Distress, self-rated
7 - Distress, rated by proxy
7 - Behavioral distress
7 - Global judgment of
satisfaction with treatment
7 - Fear of future medical
procedures




f Any single modality Identical to #6
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dence syntheses was established. Draft recommenda-
tions were refined and finalised using repeated group
conversations through email and telephone.
In accordance with GRADE methodology, good
practice statements were formulated to address practice
points for which studies were not possible or feasible but
that according to the panel underpin a comprehensive
guideline. Good practice statements were ‘ungraded’
because no formal grading of evidence can be performed
[16].
2.5. Patient and parent review
The draft recommendations were reviewed in an in-
person group meeting by a patient-parent panel (four
survivors, five parents) to consider the values and pref-
erences of children and families. Participants received a
short training session on CPG development and
contributed to the decisions regarding the direction and
strength of recommendations and to implementation
considerations (refer Supplemental Material S1).
2.6. CPG update cycle
This CPG will be updated in five years (March 2024) or
earlier should novel studies or insights warrant an earlier
update.3. Results
We retrieved 11.159 citations. Refer Fig.1 for a flow-
chart of the selection process. In all, 48 primary studies
were included (total number of participantsZ 2.271); 33
studies (n Z 1.602) and 15 studies (n Z 669) focused on
pharmacological or psychological interventions,
respectively.
In Table 2, the conclusions of included studies are
presented. The formulated recommendations (arranged
per type) and the ungraded good practice statements are
presented in Tables 3 and 4, respectively. Refer
Supplemental Materials S2 and S3 for the full evidence
summaries and Supplemental Materials S4 and S5 for
the EtD frameworks. For a flowchart to guide clinical
care, refer Fig.2.
3.1. Pharmacological interventions
The clinical questions regarding the use of pharmaco-
logical interventions are presented in Table 1. Critical
outcomes for all these questions included self-rated pain
intensity, self-rated distress, adverse effects and behav-
ioral distress. For clinical questions regarding LPs,
success of the procedure was also a critical outcome.3.1.1. Topical anesthetics
We recommend the use of a topical anesthetic for all
needle procedures (strong recommendation, low quality
of evidence).
3.1.1.1. Evidence. A total of six studies (minor proced-
ures: 3 studies (n Z 173); LPs: 3 studies (n Z 46))
informed this recommendation [17e22]. All studies
compared lidocaine-prilocaine 5% (Eutectic Mixture of
Local Anesthetics; EMLA) cream to either a placebo
or another topical anesthetic each with a 60 min
application time in needle insertion into a
subcutaneous intravenous port. Lidocaine-prilocaine
5% reduced self-rated pain intensity in four studies (no
significant difference in 2 studies) and reduced proxy-
rated distress in 3 studies (no significant difference in
three studies). Adverse effects were addressed in two
studies; there were no significant differences between
groups. Given the low number of included RCTs,
additional evidence was sought and two general
pediatrics evidence syntheses (dermal laceration repair,
vaccine injection pain) were included [23,24]. Both
syntheses concluded that topical anesthetics are
effective in reducing pain.
3.1.1.2. Evidence to decision. The panel concluded that the
desirable consequences of topical anesthetics clearly
outweigh the undesirable consequences (i.e. possible
erythema, itchiness). Required resources are small rela-
tive to the benefits, and topical anesthetics are accept-
able to key stakeholders and feasible to implement.
3.1.1.3. Implementation considerations. Topical anesthetics
used in included studies were lidocaine-prilocaine 5%
cream or patch (e.g. EMLA) and amethocaine 4% gel
(e.g. Ametop). The required application time relative
to the procedure (e.g. for lidocaine-prilocaine 5% at least
60 min before procedure) is feasible in pediatric
oncology as most procedures are planned procedures.
Healthcare providers, patients and parents should be
educated regarding application timing (e.g. when leaving
for the hospital or coming early to apply) and patch
removal technique to minimise distress. Topical
anesthetics should be introduced as early in the
treatment trajectory as possible.
3.1.2. Sedation in major procedures
We recommend the use of DS or anesthesia for major
procedures (strong recommendation, very low quality
evidence).
3.1.2.1. Evidence. Twelve studies evaluating a wide
spectrum of sedative drugs were included. Of these, two
compared different sedation levels [25,26]. GA reduced
behavioral distress compared with no sedation, with
Fig. 1. Flowchart of the selection process. Working groups are indicated using their working group number; 2C for pharmacological
management of procedure-related pain, 3B for psychological management of procedure related pain.




Minor procedures Quality of evidence
Reduced self-rated pain intensity with
lidocaine-prilocaine 5% (60 min) vs. placebo
44 LOW(18)
Reduced proxy-rated distress with lidocaine-
prilocaine 5% (60 min) vs. placebo
44 LOW(18)
No significant difference in adverse effects with
lidocaine-prilocaine 5% (60 min) vs. placebo
44 LOW(18)
Reduced self-rated pain intensity with
lidocaine-prilocaine 5% (60 min) vs.
lidocaine-prilocaine 5% (40 min)
44 LOW(17)
No significant difference in proxy-rated distress
with lidocaine-prilocaine 5% (60 min) vs.
lidocaine-prilocaine 5% (40 min)
44 LOW(17)
No significant difference in self-rated pain
intensity with lidocaine-prilocaine 5%
(60 min) vs amethocaine gel (30 min)
4 VERY
LOW(19)
No significant difference in proxy-rated distress
with lidocaine-prilocaine 5% (60 min) vs
amethocaine gel (30 min)
4 VERY
LOW(19)
No significant difference in adverse effects with
lidocaine-prilocaine 5% (60 min) vs
amethocaine gel (30 min)
4 VERY
LOW(19)
No significant difference in success of
procedure with lidocaine-prilocaine 5%
(60 min) vs amethocaine gel (30 min)
4 VERY
LOW(19)
Lumbar puncture procedures Quality of evidence
Varying results (benefit in 2 studies, no
significant difference in 1 study) with
lidocaine-prilocaine 5% vs. placebo
44 LOW(20
e22)
Reduced proxy rated distress with lidocaine-
prilocaine 5% vs. placebo
44 LOW(20
e22)
No significant difference in success of





Minor procedures Quality of evidence
No significant difference in self-rated pain
intensity with paracetamol vs. placebo
444
MODERATE (36)








No significant difference in self-rated pain
intensity with morphine vs. placebo
444
MODERATE (35)





Minor procedures Quality of evidence
No significant difference in self-rated pain
intensity with midazolam vs. placebo
44
LOW(33.34)
No significant difference in self-rated distress




Reduced self-rated distress (fear) with
midazolam vs. placebo
44 LOW(33)
Reduced behavioral distress with midazolam
vs. placebo
44 LOW(33)
Increased adverse effects with midazolam vs.
placebo
44 LOW(33)
Lumbar puncture procedures Quality of evidence
Table 2 (continued )
No significant difference in self-rated distress
with general anesthesia vs. deep sedation
44 LOW(30)
No significant difference in adverse effects with
general anesthesia vs. deep sedation
44 LOW(30)
No significant difference in success of
procedure with general anesthesia vs. deep
sedation
44 LOW(30)
No significant difference in duration of
procedure with general anesthesia vs. deep
sedation
44 LOW(30)
Major procedures Quality of evidence
No significant difference in self-rated pain




No significant difference in self-rated distress
with general anesthesia vs. no sedation
4 VERY
LOW(25)
Reduced behavioral distress with general
anesthesia vs. no sedation
4 VERY
LOW(25)
No significant difference in self-rated pain
intensity with general anesthesia vs. deep
sedation
44 LOW(26)
No significant difference in self-rated distress
with general anesthesia vs. deep sedation
44 LOW(26)
No significant difference in behavioral distress
with general anesthesia vs. deep sedation
44 LOW(26)
No significant difference in adverse effects with
general anesthesia vs. deep sedation
44 LOW(26)
Hypnosis
Minor procedures Quality of evidence















Reduced fear of future medical procedures with
hypnosis vs. standard care
444
MODERATE (40.41)
Reduced self-reported distress in parents with




Minor procedures Quality of evidence
No significant difference in self-rated pain




No significant difference in self-rated distress
with active distraction vs. standard care
44
LOW(44.45)
Reduced behavioral distress with hypnosis vs.
standard care
44 LOW(45)
No significant difference in proxy-rated distress




Lumbar puncture procedures Quality of evidence
Reduced self-rated pain intensity during and
after procedure with passive distraction vs.
standard care
44 LOW(47)
No significant difference in self-rated pain
intensity before procedure with passive
distraction vs. standard care
44 LOW(47)
No significant difference in self-rated pain
intensity with passive distraction vs.
4 VERY
LOW(48)
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Table 2 (continued )
standard care
Reduced self-rated distress with passive
distraction vs. standard care
44 LOW(47)
Combining modalities
Major procedures Quality of evidence
Reduced self-rated pain intensity post-
intervention with combining strategies vs.
single procedure
44 LOW(49)
No significant difference in self-rated pain
intensity pre-intervention with combining
strategies vs. single procedure
44 LOW(49)
Reduced self-rated distress pre-intervention
with combining strategies vs. single
procedure
44 LOW(49)
No significant difference in self-rated distress
post-intervention with combining strategies
vs. single procedure
44 LOW(49)
Varying results (with no formal testing) with




Reduced behavioral distress post-intervention
with combining strategies vs. single
procedure
44 LOW(49)
No significant difference behavioral distress
pre-intervention with combining strategies
vs. single procedure
44 LOW(49)
E.A.H. Loeffen et al. / European Journal of Cancer 131 (2020) 53e67 59no significant differences in self-rated pain intensity and
distress (1 study, n Z 18)[25]. Compared with DS, GA
showed no significant differences between groups (one
study, n Z 31) [26].
3.1.2.2. Evidence to decision. The panel concluded that
the desirable consequences of DS or GA probably
outweigh the undesirable consequences. The panel
judged that the vast majority of patients would want
to undergo a major procedure with DS or GA. Also
the panel judged that clinicians would prefer to
perform these procedures with DS or GA. The patient-
parent panel supported this recommendation
unanimously. In fact, patients who had not receive
DS or GA for major procedures stated explicitly that
they would have wanted so had they had the choice.
Although the required resources are substantial, the
panel deemed the option feasible to implement and
acceptable for institutions caring for children with
cancer.
3.1.2.3. Implementation considerations. We realise the
stratification of the sedation spectrum established by the
ASA is relatively artificial [27]. Therefore this
recommendation should be seen in the light of the
overarching aim of this CPG: optimal patient comfort,absence of restraint and successful performance of the
procedure.
The CPG panel recognised that some of the agents
evaluated in the studies informing this recommenda-
tion differ from modern practice with respect to the
provision of DS and GA. The CPG panel therefore
directs users of this CPG to current evidence-based
guidance on this topic such as the American Academy
of Pediatrics guideline on using sedation for diag-
nostic and therapeutic procedures in pediatric patients
[28].
To safely implement this recommendation, the facil-
ities to provide DS/GA should be readily available,
including the presence of an expert to administer the
anesthetic drugs and monitor the patient. At minimum,
patient monitoring requirements should comply with
local laws and regulations or the American Academy of
Pediatrics guideline on monitoring of sedation in chil-
dren may be consulted [27].
3.1.3. Sedation in lumbar punctures
We recommend that the use of DS or GA be offered to
all children undergoing lumbar punctures.
3.1.3.1. Evidence. Eight studies were included. Two
compared different sedation levels: one did not present
data in an extractable manner [29] and the other study
(n Z 22) observed no differences between GA and DS
with respect to self-rated distress, success of procedure
or adverse effects [30].
3.1.3.2. Evidence to decision. Overall the panel concluded
that the desirable consequences probably outweigh the
undesirable consequences and that the option is feasible
to implement. Furthermore, the panel took into account
the need for motion control in LPs and the body of
evidence for major procedures (several studies focused
on combined BMAs/LPs) that favored higher levels of
sedation.
Motion control is critical to the successful perfor-
mance of LPs and is often difficult to achieve without
sedation, especially in younger children. However, both
the guideline development panel and the patient-parent
panel acknowledged that there are children who may
prefer not to receive DS or GA for lumbar puncture,
and for whom no, minimal or moderate sedation and/or
psychological interventions will suffice to establish a
successful and comfortable LP [31,32]. A strong
recommendation was made to emphasise (1) the need to
determine each patient’s needs and preferences and (2)
the requirement that all levels of sedation be readily
accessible and available to all patients. When the success
Table 3
List of recommendations, presented per type of procedure.
# GRADE Recommendation text* Strengthz Quality of
evidence
Minor proceduresy
1 We recommend the use of a topical anesthetic for all needle procedures Strong Low
4 We suggest that sedatives not be used routinely for minor procedures Weak Low
5 We suggest that oral analgesics not be used for minor procedures Weak Low
6 We recommend the use of hypnosis for all needle procedures Strong Moderate
7 We recommend the use of active distraction for all needle procedures Strong Low
8 We suggest the use of passive distraction for all needle procedures Weak Very low




1 We recommend the use of a topical anesthetic for all needle procedures Strong Low
3 We recommend that the use of deep sedation or general anesthesia be offered to all children undergoing
lumbar punctures**
Strong Very low
6 We recommend the use of hypnosis for all needle procedures Strong Moderate
7 We recommend the use of active distraction for all needle procedures Strong Low
8 We suggest the use of passive distraction for all needle procedures Weak Very low




1 We recommend the use of a topical anesthetic for all needle procedures Strong Low
2 We recommend the use of deep sedation or anesthesia for major procedures Strong Very low
6 We recommend the use of hypnosis for all needle procedures Strong Moderate
7 We recommend the use of active distraction for all needle procedures Strong Low
8 We suggest the use of passive distraction for all needle procedures Weak Very low
10 We recommend combining psychological interventions with pharmacological interventions during all needle
procedures
Strong Very low
* Selection of approach should be based on the developmental stage and preferences of the patient, availability of resources and the patient’s
prior experience with the interventions and the procedure. Pharmacological interventions should be dosed appropriately. All interventions
should be administered by appropriate, qualified providers according to local legislation and medical regulations.
** The panel acknowledges that there are children who may prefer not to receive deep sedation or general anesthesia for lumbar puncture, but
instead prefer to receive no, minimal or moderate sedation and/or psychological interventions [31,32]. A strong recommendation was made to
emphasize 1) the need to determine each patient’s needs and preferences and 2) the requirement that all levels of sedation be readily accessible
and available to all patients. When the success of the procedure is not likely to be compromised, patients preferences should be honored.
y Definitions: minor procedures Z blood sampling, peripheral intravenous access, and access to central venous access port. Lumbar puncture
proceduresZ lumbar puncture procedures only (not combined procedures). Major proceduresZ bone marrow aspiration (BMA), bone marrow
puncture (BMP), combined LP with BMA/BMP, bone biopsy, organ biopsy, and echo-/radiographically guided puncture.
z Strong and weak recommendations have different implications. A strong recommendation implies that most patients in that situation would
want the recommended course of action and only a small proportion would not. For clinicians this implies that most patients should receive the
recommended course of action (which however does not omit the need for discussing options). A weak recommendation (sometimes called
conditional, discretionary, or qualified) implies that most patients in that situation would want the recommended course of action, but many
would not. For clinicians this implies that they should recognize that different choices will be appropriate for different patients and that one must
help each patient to arrive at a management decision consistent with her or his values and preferences [15].
E.A.H. Loeffen et al. / European Journal of Cancer 131 (2020) 53e6760of the procedure is not likely to be compromised, the
patient preferences should be honored.
3.1.3.3. Implementation considerations. Refer implementa-
tion considerations presented for the use of DS or GA
for major procedures.
3.1.4. Sedation for minor procedures
We suggest that sedatives not be used routinely for
minor procedures (weak recommendation, low quality
evidence).
3.1.4.1. Evidence. Two studies (n Z 93) compared mid-
azolam to placebo in needle insertion into asubcutaneous intravenous port [33,34]. No differences
between groups were found for self-rated outcomes
(pain intensity and distress), except for reduced self-
rated fear in one study [33,34]. In one study,
midazolam reduced behavioral distress but was also
associated with adverse effects (e.g. anger, over-
sedation) [33].3.1.4.2. Evidence to decision. Appraising the limited evi-
dence, the panel concluded that the desirable conse-
quences of the use of sedatives probably do not
outweigh the undesirable consequences. In addition, the
panel judged that sedative use is not acceptable to key
Table 4
List of good practice statements.
Ungraded good practice statements
Prior to all needle procedures, healthcare providers, children and parents should be educated and prepared regarding needle procedures and
interventions to reduce pain and distress.
The child and his/her family should always be consulted in determining the appropriate management strategy to reduce procedure-related pain and
distress.
Healthcare professionals should offer parents the option to be present during their child’s needle procedures if the child wishes to.
Throughout the course of treatment, children should have ongoing assessments and re-assessments of pain and distress and the appropriateness of
interventions should be re-assessed to determine the continued effectiveness of strategies to reduce procedural pain and distress.
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regarding other sedatives was lacking.
3.1.4.3. Implementation considerations. There may be a
subset of children who are extremely anxious before
and/or during minor procedures for whom sedation
might be beneficial [28].
3.1.5. Oral analgesics in minor procedures
We suggest that oral analgesics not be used for minor
procedures (weak recommendation, low quality
evidence).
3.1.5.1. Evidence. Two placebo-controlled studies
(n Z 101) were included, one focusing on oral
acetaminophen (paracetamol) and one on oral
morphine. Both found no significant differences in
self-rated pain intensity [35,36]. Acetaminophen
reduced self-rated distress and behavioral distress [36].
Morphine increased self-rated distress [35].
In the systematic search for general pediatrics evi-
dence syntheses, one vaccine pain CPG was included.
This CPG recommended against acetaminophen use due
to a lack of evidence [37].
3.1.5.2. Evidence to decision. In formulating this recom-
mendation, the CPG panel considered both the included
evidence and the wide between-patient variability of
analgesic bioavailability and time to maximum effect.
Thus, coordinating the procedure with the peak
analgesic effect would be logistically difficult. Overall,
the panel concluded that the undesirable consequences
of analgesics outweigh their uncertain desirable effects.
3.2. Psychological interventions
The included clinical questions on psychological in-
terventions focused on hypnosis, active distraction and
passive distraction (reer Table 1). Critical outcomes for
all these questions were self-rated pain intensity, self-
rated distress, proxy-rated distress, behavioral distress,
fear of future medical procedures, adverse effects and,for the questions on distraction, global judgement of
satisfaction with treatment.
Hypnosis was defined as a trance-like state aware-
ness, where a child is highly focused on (suggested or
self-created) images or ideas. Active distraction was
defined as distraction in which a child actively partici-
pates, for example, completing a puzzle or playing a
computer game. Passive distraction was defined as
distraction in which a child does not actively partici-
pate, for example, listening to music or watching a
movie.
It should be noted that in procedures where DS or
GA is used, the use of psychological interventions is
limited to the preparation phase.
3.2.1. Hypnosis
We recommend the use of hypnosis for all needle pro-
cedures (strong recommendation, moderate quality
evidence).
3.2.1.1. Evidence. Four studies (n Z 120), all from one
study group, compared the use of hypnosis to standard
care during minor procedures, LPs and major proced-
ures [38e41]. In all studies, hypnosis reduced self-rated
pain intensity, self-rated distress and behavioral
distress; in two studies, hypnosis reduced fear of future
medical procedures.
3.2.1.2. Evidence to decision. The panel concluded that
the desirable consequences of hypnosis clearly
outweigh the undesirable consequences. In addition,
hypnosis is feasible to implement (although formal
training is required) and acceptable to stakeholders.
Thus, the CPG panel made a strong recommendation
based on the consistent demonstration of benefit of
hypnosis and the low likelihood of harm. This recom-
mendation was unanimously supported by the patient-
parent panel.
3.2.1.3. Implementation considerations. The patient-parent
panel emphasised the need to eliminate misconceptions
about hypnosis through education. To implement
hypnosis, professionals need to be trained to use this
Fig. 2. Flowchart summarizing the recommendations to reduce procedural pain and distress, for use in clinical practice.
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patients to perform self-hypnosis.
3.2.2. Active distraction
We recommend the use of active distraction for all
needle procedures (strong recommendation, low quality
evidence).
3.2.2.1. Evidence. Five studies (n Z 171) evaluated the
use of active distraction compared with standard care
during minor procedures [42e45]. Although several
critical outcomes were not reported in sufficient detail
to extract data, active distraction reduced behavioral
distress (one study), with no significant differences for
self-rated pain intensity (one study), and self- and
proxy-rated distress (two studies).
3.2.2.2. Evidence to decision. As there is a low likelihood
that distraction causes harm, even small benefits can be
of value, and the panel thus concluded that the desirable
consequences probably outweigh the undesirable con-
sequences (if any). Distraction interventions can be oflow cost and therefore accessible in nearly all settings.
The parent-patient panel unanimously underlined the
strong recommendation.
3.2.2.3. Implementation considerations. The parent-patient
panel emphasised the need to take the time, together
with the child, to select the preferred distraction. In
addition, from the literature (and from the experience of
our patient-parent panel), we know that there are people
who benefit from knowing and seeing what is going on
and therefore prefer not to be distracted [46].
3.2.3. Passive distraction
We suggest the use of passive distraction for all needle
procedures (weak recommendation, very low quality
evidence).
3.2.3.1. Evidence. Two studies (nZ 70) evaluated the use
of passive distraction compared with standard care
during LPs [47,48]. In one study, passive distraction
reduced self-rated anxiety and self-rated pain intensity
during and after (but not before) the procedure [47].
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rated pain intensity [48].
3.2.3.2. Evidence to decision. The panel concluded that the
desirable consequences probably outweigh the undesir-
able consequences, with the option being feasible and
acceptable. However, given the very low overall quality
of the evidence and the focus of the included studies on
LPs only, the panel preferred active distraction over
passive distraction and thus categorised this recom-
mendation as weak.
3.2.3.3. Implementation considerations. Refer the imple-
mentation considerations paragraph of active distrac-
tion. As no person is needed to interact with the child,
passive distraction might be more simple to implement
than active distraction.
3.3. Combining intervention modalities
We recommend combining psychological interventions
with pharmacological interventions during all needle
procedures (strong recommendation, very low quality
evidence).
3.3.1. Evidence
Two studies (n Z 175) compared combined in-
terventions (valium and cognitive behavioral therapy in
one study, midazolam/morphine and play/guided imag-
ery in the other) to single interventions in major pro-
cedures [49,50]. In one study, combining intervention
modalities reduced self-rated pain intensity post-
intervention (but not pre-intervention), self-rated
distress pre-intervention (but not post-intervention) and
behavioral distress post-intervention (but not pre-
intervention) [49].
3.3.2. Evidence to decision
Given the available evidence and the previous strong
recommendations for several single interventions among
different modalities, the panel judged a strong recom-
mendation for combining appropriate interventions as
justifiable. Combining psychological and pharmacolog-
ical interventions is generally feasible and acceptable to
key stakeholders. This recommendation was also based
on the included studies on psychological interventions
that included pharmacological interventions as part of
standard care.
3.3.3. Implementation considerations
Other than situations where combining modalities is not
applicable (e.g. during DS), the panel judged that cli-
nicians should always strive to combine recommended
pharmacological interventions (e.g. topical anesthetics)
with recommended psychological interventions (e.g.
active distraction) to optimise pain/distress
management.3.4. Ungraded good practice statements
3.4.1. Education and preparation
Before all needle procedures, healthcare providers,
children and parents should be educated and prepared
regarding needle procedures and interventions to reduce
pain and distress (ungraded good practice statement).
Both the CPG panel and the patient-parent panel
deemed education and preparation (starting as early as
possible in the treatment process) to be critical to the
provision of high-quality, patient-centered care of chil-
dren undergoing procedures. This might be partly
covered in the process of gaining informed consent.
Children and parents should be informed about the
meaning and process of each procedure and about what
measures can be taken to reduce pain and distress. This
can effectively decrease distress and increase coping and
compliance during a variety of medical procedures [51].
In addition, healthcare providers need to be trained on
effective procedural pain and distress management
strategies.
3.4.2. Empowerment
The child and his/her family should always be consulted
in determining the appropriate management strategy to
reduce procedure-related pain and distress (ungraded
good practice statement).
Healthcare providers should always engage a child
and their parents in the selection of effective in-
terventions to reduce procedural pain and distress.
Developmental age, personality, gender and cultural
factors may all play a role in the success of an inter-
vention. An informed decision on the preferred strategy
should be made together. The patient-parent panel
emphasised the autonomy of the child by saying: put the
child in charge. Several projects are being undertaken
that contribute to this aim, for instance, the Comfort,
Ask, Relax, Distract (CARD) project in which patient
empowerment is combined with education, for patients
as well as healthcare providers [55].
3.4.3. Presence of parents
Healthcare professionals should offer parents the option
to be present during their child’s needle procedures if the
child wishes to (ungraded good practice statement).
Parental presence might facilitate patient distraction
and/or comfort and if desired the parents can act as a
coach for their child. During preparation and education,
parents should be informed about what behaviors and
techniques are helpful to decrease distress and increase
coping.
3.4.4. Ongoing pain assessments
Throughout the course of treatment, children should
have ongoing assessments and re-assessments of pain
and distress and the appropriateness of interventions
should be re-assessed to determine the continued
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distress (ungraded good practice statement).
Intervention effectiveness may vary over the course of
a child’s cancer treatment, and their preferences and
capabilities might change. A child’s willingness to accept
certain interventions is among other things influenced by
the pain and distress experienced during past proced-
ures. This may not have a linear trajectory. For instance,
a negative procedure experience (e.g. more distressing,
multiple attempts before success) can provoke increased
levels of fear, which may call for a different approach
with regard to managing procedural pain and distress in
the future.3.5. Recommendations for research
The panel identified several evidence gaps (refer
SupplementalMaterials S4andS5).Overall, thepanel calls
for large, multicenter RCTs that evaluate the critical out-
comes defined in this guideline. Inparticular, head-to-head
intervention comparison trials and cost-effectiveness trials
for sedation drugs, use of nitrous oxide, virtual reality for
distraction and trials in which different combinations of
treatment modalities are compared are needed. Devel-
oping specific guidance for children with developmental
disorders would also be of interest.
Future studies should take into account the long
treatment trajectories with repeated procedures that
children with cancer often undergo. Most current
studies focus on one procedure. However, an interven-
tion can be effective for one procedure but ineffective
over time due to increases in pain and/or distress.
Therefore, longitudinal design studies taking into ac-
count pain and distress over multiple procedures and
other relevant outcomes such as psychological sequelae,
compliance behavior and quality of life are needed.
The patient-parent panel emphasised that attention
should be placed on identifying optimal ways to put the
child in charge of their own procedure experience.
Children should be fully and optimally facilitated to
explore possibilities and formulate their own approach
to pharmacological and psychological management of
procedure-related pain and distress, within the bound-
aries of what is clinically possible and appropriate.4. Discussion
Throughout the course of treatment, children with
cancer undergo frequent, repeated procedures that are
associated with high levels of pain and distress [4]. In
this CPG, we have formulated recommendations to
reduce pain and distress during these procedures to
improve health-related quality of life for children with
cancer and their families.
This CPG endeavor benefited from an interna-
tional and interprofessional CPG development panel.We believe this contributed significantly to the in-
ternational applicability of the recommendations.
However, we included only one healthcare profes-
sional from a nonehigh-income country. Although
some of the recommendations are feasible in lower
income settings (e.g. use of distraction), this may not
be the case for all recommendations. We have pro-
vided detailed evidence summaries, accompanying
EtD frameworks, transparent reports of the justifi-
cation for each recommendation and implementation
considerations to facilitate local adaptation of the
recommendations.
Use of the rigorous methodology of the GRADE
working group increases the credibility of our recom-
mendations [14]. Inclusion of patients and parents in the
recommendation formulation process and integrating
their perspective increased the applicability and useful-
ness of our recommendations. The panel placed high
value on using a patient-centered approach, as is also
increasingly promoted [52,53].
This CPG is limited by the scarcity of direct evidence
available to address our clinical questions. Few high-
quality studies have been performed that focus on alle-
viating procedural pain in children with cancer. The
GRADE group acknowledges the frustration of clini-
cians when a CPG does not succeed in providing guid-
ance, and therefore encourages guideline developers to
attempt to formulate recommendations even when
confidence in the effect estimate is low [54]. The scarcity
of direct evidence calls for high-quality RCTs to be
conducted in this field.
In addition, there might be subgroups of patients for
whom these recommendations might not be applicable
and who could benefit from recommendations tailored
to their specific situation. For example, this might be
true for children with severe procedural distress/needle
phobia.
Pain and distress from repeated procedures is often
a great burden for children with cancer and their
families. Our group has formulated recommendations
to guide healthcare professionals in daily practice,
aimed at reducing this suffering. It is critical that cli-
nicians recognise the great between-patient variability
in the severity of procedural pain and distress.
Therefore, tailoring our recommendations to the in-
dividual child is of utmost importance. This approach
will result in improved care for children with cancer
undergoing painful procedures, thereby reducing
suffering and potentially enhancing health-related
quality of life.Disclaimer
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